作者: Bradley J. Erickson , Norbert G. Campeau , Shawn A. Schreiner , Jan C. Buckner , Brian P. O’Neill
关键词:
摘要: PURPOSE: Triple-dose (TD) gadolinium contrast administration and magnetization transfer suppression (MTS) in brain magnetic resonance imaging (MRI) have proven to be useful for demonstrating additional enhancing lesions some diseases. The purpose of this study was determine if there is a subset tumors that demonstrate enhancement with TD MTS do not enhance standard dose.